Lumida
/NKTX
⌘K
Nkarta Inc

Nkarta Inc

NKTX
$2.60USD+0.00%+0.00 today

MARKET CAP

186.0M

P/E (TTM)

FWD P/E

DAY RANGE

$3 – $3

52W RANGE

$2
$4

AI Summary

Stalk
Buy NowMedium

NKTX exhibits a clear sequence of higher highs and higher lows within a Stage 2 advance, with price accepting pullbacks into rising EMAs and reclaiming support. The medium-term structure remains bullish, reinforced by our Speculative strategy’s preference for continuation setups. Short-term timing is favorable as price tracks above the 9/20 EMAs and rebounds from recent consolidation. We recommend engaging now on a pullback interaction around the EMA zone, targeting continuation of the established uptrend.

  • Cash burn down 16% to ~$88M/year; $230M reserves support 2.6-year runway
  • FDA-approved Ntrust-1/2 protocol changes reduce patient burden and speed trials
  • Q1’26 net loss of $0.37/shr vs. est. $0.38; no revenue generation
Full analysis →
Insider Trades24 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Jun 18, 2026SellNKTXPaul J HastingsChief Executive Officer1,776$2.71$186.0M-30.11%+52.94%$4.8K-0.45%Buy Now
Jan 15, 2026SellNKTXNadir MahmoodPresident5,649$2.07$186.0M-30.11%+52.94%$11.7K-3.26%Buy Now
Jan 15, 2026SellNKTXPaul J HastingsChief Executive Officer26,046$2.07$186.0M-30.11%+52.94%$53.9K-6.26%Buy Now
Jun 18, 2025SellNKTXPaul J HastingsChief Executive Officer1,790$1.79$186.0M-30.11%+52.94%$3.2K-0.56%Buy Now
Jan 15, 2025SellNKTXAlyssa Levin5,838$2.20$186.0M-30.11%+52.94%$12.8K-5.38%Buy Now
Jan 15, 2025SellNKTXRalph BrandenbergerChief Technical Officer7,447$2.20$186.0M-30.11%+52.94%$16.4K-5.63%Buy Now
Jan 15, 2025SellNKTXDavid Shook8,638$2.20$186.0M-30.11%+52.94%$19.0K-4.33%Buy Now
Jan 15, 2025SellNKTXAlicia J. HagerChief Legal Officer9,584$2.20$186.0M-30.11%+52.94%$21.1K-6.13%Buy Now
Jan 15, 2025SellNKTXPaul J HastingsChief Executive Officer17,378$2.20$186.0M-30.11%+52.94%$38.2K-5.15%Buy Now
Aug 21, 2024BuyNKTXDavid Shook1,352$5.11$186.0M-30.11%+52.94%$6.9K+0.99%Buy Now
Jul 16, 2024SellNKTXAlicia J. HagerChief Legal Officer3,396$8.00$186.0M-30.11%+52.94%$27.2K-3.17%10b5-1Buy Now
Jun 18, 2024SellNKTXRalph BrandenbergerChief Technical Officer229$5.60$186.0M-30.11%+52.94%$1.3K-0.29%Buy Now
Jun 18, 2024SellNKTXDavid ShookChief Medical Officer456$5.60$186.0M-30.11%+52.94%$2.6K-0.39%Buy Now
Jun 18, 2024SellNKTXJames TragerChief Scientific Officer456$5.60$186.0M-30.11%+52.94%$2.6K-0.30%Buy Now
Jun 18, 2024SellNKTXAlicia J. HagerChief Legal Officer727$5.60$186.0M-30.11%+52.94%$4.1K-0.67%Buy Now
Jun 18, 2024SellNKTXPaul J HastingsChief Executive Officer1,770$5.60$186.0M-30.11%+52.94%$9.9K-0.73%Buy Now
Mar 1, 2024SellNKTXRalph BrandenbergerChief Technical Officer15,130$8.66$186.0M-30.11%+52.94%$131.0K-0.53%10b5-1Buy Now
Feb 12, 2024SellNKTXJames TragerChief Scientific Officer4,143$12.00$186.0M-30.11%+52.94%$49.7K-2.70%10b5-1Buy Now
Jan 16, 2024SellNKTXRalph BrandenbergerChief Technical Officer2,512$8.74$186.0M-30.11%+52.94%$22.0K-2.99%Buy Now
Jan 16, 2024SellNKTXDavid ShookChief Medical Officer3,552$8.74$186.0M-30.11%+52.94%$31.0K-3.00%Buy Now
Jan 16, 2024SellNKTXAlicia J. HagerChief Legal Officer4,554$8.74$186.0M-30.11%+52.94%$39.8K-4.05%Buy Now
Jan 16, 2024SellNKTXJames TragerChief Scientific Officer4,560$8.74$186.0M-30.11%+52.94%$39.9K-2.88%Buy Now
Jan 16, 2024SellNKTXPaul J HastingsChief Executive Officer9,697$8.74$186.0M-30.11%+52.94%$84.8K-2.42%Buy Now
Aug 21, 2023SellNKTXDavid ShookChief Medical Officer1,331$1.83$186.0M-30.11%+52.94%$2.4K-2.15%Buy Now